{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T13:12:37Z","timestamp":1694351557375},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00277-023-05414-z","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T16:02:21Z","timestamp":1692288141000},"page":"2735-2740","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?"],"prefix":"10.1007","volume":"102","author":[{"given":"Andrea","family":"Corbingi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Putzulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Massini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gessica","family":"Minnella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Chiusolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"21","key":"5414_CR1","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1182\/blood-2014-10-551507","volume":"125","author":"C Rollig","year":"2015","unstructured":"Rollig C, Ehninger G (2015) How I treat hyperleukocytosis in acute myeloid leukemia. Blood 125(21):3246\u20133252","journal-title":"Blood"},{"issue":"8","key":"5414_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3949\/ccjm.71.8.633","volume":"71","author":"NS Majhail","year":"2004","unstructured":"Majhail NS, Lichtin AE (2004) Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med 71(8):633\u2013637","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"5414_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/17474086.2017.1270754","volume":"10","author":"S Giammarco","year":"2016","unstructured":"Giammarco S, Chiusolo P, Piccirillo N et al (2016) Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Rev Hematol 10(2):147\u2013154","journal-title":"Expert Rev Hematol"},{"key":"5414_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/cells8010066","volume":"8","author":"AM Gruszka","year":"2019","unstructured":"Gruszka AM, Valli D, Restelli C et al (2019) Adhesion deregulation in acute myeloid leukaemia. Cells 8:66","journal-title":"Cells"},{"key":"5414_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jca.20290","volume":"26","author":"GC De Santis","year":"2011","unstructured":"De Santis GC, Correa Oliveira de Oliveira L, Maltoni Romano LG et al (2011) Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia. J Clin Apheresis 26:181\u2013185","journal-title":"J Clin Apheresis"},{"issue":"2310","key":"5414_CR6","first-page":"1","volume":"9","author":"JP Bewersdorf","year":"2020","unstructured":"Bewersdorf JP, Zeidan AM (2020) Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments? Cells 9(2310):1\u201320","journal-title":"Cells"},{"key":"5414_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1600-0609.2005.00421.x","volume":"74","author":"JR Novotny","year":"2005","unstructured":"Novotny JR, Muller-Bei\u00dfenhirtz H, Herget-Rosenthal S et al (2005) Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome. Eur J Haematol 74:501\u2013510","journal-title":"Eur J Haematol"},{"issue":"6","key":"5414_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ajh.21418","volume":"84","author":"N Piccirillo","year":"2009","unstructured":"Piccirillo N, Laurenti L, Chiusolo P et al (2009) Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis. Am J Hematol 84(6):381\u2013382","journal-title":"Am J Hematol"},{"key":"5414_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.blre.2012.01.003","volume":"26","author":"C Ganzel","year":"2012","unstructured":"Ganzel C, Becker J, Mintz PD et al (2012) Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev 26:117\u2013122","journal-title":"Blood Rev"},{"issue":"11","key":"5414_CR10","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1080\/10428194.2018.1452219","volume":"59","author":"M Stahl","year":"2018","unstructured":"Stahl M, Pine A, Hendrickson JE et al (2018) Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey. Leukemia Lymphoma 59(11):2723\u20132726","journal-title":"Leukemia Lymphoma"},{"key":"5414_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jca.21705","volume":"34","author":"A Padmanabhan","year":"2019","unstructured":"Padmanabhan A, Connelly-Smith L, Aqui N et al (2019) Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher 34:171\u2013354","journal-title":"J Clin Apher"},{"issue":"20","key":"5414_CR12","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"issue":"4","key":"5414_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u2013447","journal-title":"Blood"},{"key":"5414_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1155\/2013\/582569","volume":"35","author":"P Singh Chauhan","year":"2013","unstructured":"Singh Chauhan P, Ihsan R, Singh LC et al (2013) Mutation of NPM1 and FLT3 genes in acute myeloid leukemia and their association with clinical and immunophenotypic features. Dis Markers 35:581\u2013588","journal-title":"Dis Markers"},{"issue":"10","key":"5414_CR15","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1182\/blood-2005-08-3167","volume":"107","author":"C Thiede","year":"2006","unstructured":"Thiede C, Koch S, Creutzig E et al (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 107(10):4011\u20134020","journal-title":"Blood"},{"issue":"6","key":"5414_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1182\/bloodadvances.2019001335","volume":"4","author":"G Juliusson","year":"2020","unstructured":"Juliusson G, J\u00e4dersten M, Deneberg S et al (2020) The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting. Blood Adv 4(6):1094\u20131101","journal-title":"Blood Adv"},{"issue":"9","key":"5414_CR17","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1080\/10428194.2016.1277386","volume":"58","author":"X Nana","year":"2017","unstructured":"Nana X, Qina Q, Gentillea C et al (2017) Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis \u2013 a retrospective study from a tertiary center. Leuk Lymphoma 58(9):2110\u20132117","journal-title":"Leuk Lymphoma"},{"key":"5414_CR18","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1111\/trf.16091","volume":"60","author":"L Connelly-Smith","year":"2020","unstructured":"Connelly-Smith L, Linenberger ML (2020) Leukocytapheresis for AML hyperleukocytosis: failing to make the grade. Transfusion 60:2161\u20132163","journal-title":"Transfusion"},{"issue":"12","key":"5414_CR19","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1038\/s41375-020-0783-3","volume":"34","author":"M Stahl","year":"2020","unstructured":"Stahl M, Shallis RM, Wei W et al (2020) Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multi-center, international study. Leukemia 34(12):3149\u20133160","journal-title":"Leukemia"},{"key":"5414_CR20","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.leukres.2008.01.004","volume":"32","author":"L Marbello","year":"2008","unstructured":"Marbello L, Ricci F, Maria Nosari A et al (2008) Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res 32:1221\u20131227","journal-title":"Leuk Res"},{"issue":"4","key":"5414_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0095062","volume":"9","author":"F Pastore","year":"2014","unstructured":"Pastore F, Pastore A, Wittmann GW et al (2014) The role of therapeutic leukapheresis in hyperleukocytotic AML. PLoS ONE 9(4):1\u201311","journal-title":"PLoS ONE"},{"issue":"4","key":"5414_CR22","first-page":"0243","volume":"11","author":"I Kuku","year":"2021","unstructured":"Kuku I, Kaya E, Erkurt MA et al (2021) Therapeutic and prophylactic leukapheresis in hyperleukocytositic leukaemias; our experiences. Ann Med Res 11(4):0243\u20130246","journal-title":"Ann Med Res"},{"key":"5414_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jca.22043","volume":"38","author":"L Connelly-Smith","year":"2023","unstructured":"Connelly-Smith L, Alquist CR et al (2023) Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue. J Clin Apher 38:77\u2013278","journal-title":"J Clin Apher"},{"issue":"5","key":"5414_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/17474086.2020.1751609","volume":"13","author":"RM Shallis","year":"2020","unstructured":"Shallis RM, Stahl M, Bewersdorf JP et al (2020) Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits. Expert Rev Hematol 13(5):489\u2013499","journal-title":"Expert Rev Hematol"},{"key":"5414_CR25","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.2147\/IJGM.S321787","volume":"14","author":"D Zhang","year":"2021","unstructured":"Zhang D, Zhu Y, Jin Y et al (2021) Leukapheresis and hyperleukocytosis, past and future. Int J Gen Med 14:3457\u20133467","journal-title":"Int J Gen Med"},{"key":"5414_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.transci.2015.03.015","volume":"53","author":"I Berber","year":"2015","unstructured":"Berber I, Kuku I, Erkurt MA et al (2015) Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: a single center experience. Transfus Apheres Sci 53:185\u2013190","journal-title":"Transfus Apheres Sci"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05414-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05414-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05414-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T10:06:33Z","timestamp":1694253993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05414-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5414"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05414-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}